LIMB-GIRDLE MUSCULAR DYSTROPHY Disease-state awareness · Patient

THE CHALLENGE
Limb-girdle muscular dystrophy (LGMD) isn’t one disease — it’s more than 30 genetically distinct subtypes, each with different proteins, symptoms, and progression, and a definition that keeps being reclassified as the science moves. Most people spend years in a diagnostic odyssey, often misdiagnosed, with almost no clear, trustworthy resource to turn to. The brief was to build the most comprehensive, accessible LGMD resource available — and to drive one urgent action: get a genetic test, learn your subtype, so you’re ready when treatment comes.

THE APPROACH
My design partner and I built this one top to bottom, together, workshopping every page, from strategy and information architecture to content mapping to final copy. The core challenge was translation: making 30+ subtypes and a shifting research landscape clear without oversimplifying and holding scientific accuracy and patient-friendly language in the same sentence. We structured the whole experience around the patient’s real path — clinical suspicion → genetic testing → subtype → what’s next — with a subtype-exploration tool to turn overwhelming complexity into a navigable, motivating next step. Throughout, we presented emerging treatments with both hope and realism, never overpromising to people who’ve been let down before.

THE WORK
A full unbranded DSA site: creative concept, a ground-up content architecture and sitemap for a famously un-mappable disease, a subtype search-and-filter tool, and all patient-facing copy, built to be the clearest LGMD resource available and to scale as the science evolved.

MY ROLE
I owned all the content and copy and co-led the project end-to-end with my design partner — strategy, information architecture, content mapping, and copy, workshopped page by page. It was rare-disease translation at its hardest: ultra-complex science made clear, accurate, and human.